1. Executive Summary 2. Research Methodology 3. Neurovascular Market 3.1 Introduction 3.1.1 Background 3.1.2 Neurovascular Devices 3.2 Market Analysis 3.2.1 Market Sizing (Actual & Forecasted) 3.2.2 Market Share by Region 3.2.3 Market Share by Therapeutic Application 3.2.4 Market Share by Technique 4. Global Neurovascular Market Segmentation 4.1 Cerebral Thrombectomy Devices 4.1.1 Overview 4.1.2 Market Sizing (Actual & Forecasted) 4.1.3 Market Share by Region 4.2 Flow Diverter for Aneurysm 4.2.1 Overview 4.2.2 Market Sizing 4.2.3 Market Share 4.3 Carotid Artery Stenting (CAS) System 4.3.1 Overview 4.3.2 Market Sizing 4.3.3 Market Share by Region 5. The US Neurovascular Intervention Market 5.1 Market Analysis 5.1.1 Market Sizing (Actual & Forecasted) 5.1.2 Market Share by Segment 5.2 Market Segmentation 5.2.1 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted) 5.2.2 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted) 5.2.3 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted) 6. Global Neurovascular Market Dynamics 6.1 Industry Trends & Developments 6.1.1 Mergers & Acquisitions 6.1.2 Technological Advancement 6.1.3 Minimally Invasive Techniques 6.2 Growth Drivers 6.2.1 Rising Prevalence of Cerebrovascular disease 6.2.2 Higher Incidences of Neurological Disorders 6.2.3 Favorable Reimbursement Policies 6.2.4 Expanding Healthcare Infrastructure 6.3 Challenges 6.3.1 High Cost of Treatment 6.3.2 Multiple Product Recalls 6.3.3 Dearth of Skilled Neurosurgeons 6.3.4 Social Stigma 7. Competitive Landscape 7.1 Global 7.2 The US 8. Company Profiles 8.1 Johnson & Johnson DePuy Synthes 8.2 Stryker Corporation 8.3 Medtronic Plc. 8.4 Penumbra Inc. 8.5 Terumo Corporation

Figure 1: Rockville Research – Research Methodology Table 1: Classification of Neurological Medical Devices Table 2: Major Neurovascular Products Figure 2: Global Neurovascular Intervention Market Size by Value, 2008-16 (US$ Billions) Figure 3: Global Neurovascular Intervention Market Size by Value Forecasted, 2017E-22E (US$ Billions) Figure 4: Global Therapeutic Neurovascular Intervention Device Market Share by Region (2016E) Figure 5: Global Neurovascular Intervention Market Share by Therapeutic Application (2016E) Figure 6: Global Neurovascular Intervention Market Share by Technique (2016E) Table 3: New Generation Cerebral Thrombectomy Devices Figure 7: Global Cerebral Thrombectomy Devices Market Size by Value, Figure 8: Global Cerebral Thrombectomy Devices Market Share by Region (2016) Table 4: Flow Diverter Devices Figure 9: Global Flow Diverting Aneurysm Devices Market Size by Value, 2013-22E (US$ Millions) Figure 10: Global Flow Diversion Market Share by Region Figure 11: Global Carotid Artery Stenting (CAS) System Market Size by Value, 2013-22E (US$ Millions) Figure 12: Global Carotid Artery Stenting (CAS) Systems Devices Market Share by Region (2016E) Figure 13: The US Neurointervention Systems Market Size by Value, 2013-22E (US$ Billions) Figure 14: The US Neurointervention Systems Market Share by Segment (2016) Figure 15: The US Cerebral Thrombectomy Devices Market Size by Value, 2013-22E (US$ Millions) Figure 16: The US Carotid Artery Stenting (CAS) Systems Devices Market Size by Value, 2013-22E (US$ Millions) Figure 17: The US Carotid Artery Stenting (CAS) Systems Devices Market Size by Value, 2013-22E (US$ Millions) Table 5: Mergers & Acquisitions in Neurovascular Intervention Market Figure 18: Global Stroke Incidences, 2009-16 (Millions) Table 6: Number of Disability-Adjusted Life Years (DALYs) for Neurological Disorders and as Percentage of Global DALYs Projected for 2005, 2015 And 2030 (Thousands) Table 7: Deaths Attributable to Neurological Disorders as Percentage of Total Deaths, 2005, 2015 And 2030 Table 8: Major Neurovascular Companies – Competitive Landscape Figure 19: Global Neurovascular Intervention Market Share by Competitors (2016E) Figure 20: Global Carotid Artery Stenting (CAS) Market Share by Competitors (2016) Figure 21: The US Cerebral Thrombectomy Devices Market Share by Competitors (2016E) Figure 22: Johnson & Johnson Revenue by Business Segment (FY2016) Figure 23: Johnson & Johnson Net Sales, FY2012-FY2016 (US$ Billions) Figure 24: Stryker Corporation Revenue by Business Segment (FY2016) Figure 25: Stryker Corporation Net Sales, FY2012-FY2016 (US$ Billions) Figure 26: Medtronic Plc. Revenue by Business Segment (FY2017) Figure 27: Medtronic Plc. Net Sales, FY2012-FY2017 (US$ Billions) Figure 28: Penumbra Inc. Revenue by Business Segment (FY2017) Figure 29: Penumbra Inc.Net Sales, FY2012-FY2017 (US$ Billions) Figure 30: Terumo Corporation Revenue by Business Segment (FY2017) Figure 31: Terumo Corporation Net Sales, FY2012-FY2017 (US$ Billions)

Johnson & Johnson DePuy Synthes, Stryker Corporation, Medtronic Plc., Penumbra Inc., Terumo Corporation